Dublin, Ireland (PRWEB) February 26, 2013
Research and Markets has announced the addition of the "Aortic Endografts Market" report to their offering.
The global aortic stent grafts market grew by 12% during 2012 and closed the year touching $1.8 billion in revenue. New generation of lower profile devices were rolled out during the year which further expanded the universe of patients eligible for endovascular repair and the overall market.
According to thought leaders, the years ahead promise to be even more exciting. Paradigms will be shifted and innovation will accelerate to meet the remaining challenges of the aorta and before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly.
Aortic Endografts Market attempts to answer some important questions regarding the fast evolving aortic endografts landscape. The report analyzes revenue and growth trends for the entire market with special emphasis on abdominal, thoracic and fenestrated stent graft segments.
Aortic Endografts Market is targeted at senior executives in the medical device industry who wish to get up-to-date with this two billion dollar fast growing market.
Key Topics Covered:
1. Executive Summary
2. Aortic Aneurysms
3. Global Aortic Stent Grafts Market
4. Anatomical Segmentation of Aortic Endografts Market
5. Geographical Segmentation of Aortic Endografts Market
6. Aortic Endografts Market Forecast
Companies Mentioned in this report include Altura, Aptus Endosystems, Bolton Medical, Braile Biomedica, Cardiatis, Cook Medical, Endologix, Lifetech Scientific, Gore Medical, Johnson & Johnson, Jotec, Lombard Medical, Medtronic, Microport Medical, Nano Endoluminal, Terumo and TriVascular.
For more information visit http://www.researchandmarkets.com/research/drwt94/aortic_endografts
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices